logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Huajian Medical: Reached a strategic cooperation with Renhe International, a wholly-owned subsidiary of Renhe Pharmaceutical Group.

date
16/09/2025
Huajian Medical Announcement: The company, together with Renhe Pharmaceutical, an indirectly wholly-owned subsidiary, has reached a strategic cooperation with Renhe International to jointly establish the world's first vertical RWA exchange dedicated to over-the-counter drugs in the United States.
Latest
now
Multiple factors ferment, and the concept of cars is generally rising.
1 m ago
Citigroup updates Ethereum forecast: the baseline scenario will drop to $4300 by the end of the year.
2 m ago
Tesla's after-hours trading increase expanded to 2% and Musk plans to conduct a technical evaluation of the AI5 chip design on Saturday. Next week, a meeting will be held on artificial intelligence/autonomous driving systems, Optimus robots, and vehicle production.
2 m ago
Insider: the announcement of the EU's new sanctions against Russia has been indefinitely postponed.
3 m ago
Hong Kong stocks unusual movement | Fosun Pharma (02696.HK) rose more than 9% during trading, company is reportedly negotiating with Johnson & Johnson and Roche regarding HLX43 related authorization.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.